FDA Approves New Drug Treatment for Type 2 Diabetes

July 31, 2009--The U.S. FDA today approved Onglyza (saxagliptin), a once-daily tablet to treat Type 2 diabetes in adults. The medication is intended to be used with diet and exercise to control high blood sugar levels.

The details can be read here.